Condition 1: Inflammatory bowel disease. Condition 2: Inflammatory bowel disease. Crohn disease [regional enteritis] Ulcerative colitis
Conditions
Interventions
Intervention 1: In this study, the type of intervention in the form of a written copy of the information prescribed by a doctor.Patients in the intervention group in addition to the usual information
Prevention
In this study, the type of intervention in the form of a written copy of the information prescribed by a doctor.Patients in the intervention group in addition to the usual information that is given to
Patients in control group only received verbal information typically provided by your doctor, and the doctor does not receive health information.
Sponsors
Tabriz University of Medical Sciences Research Council
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with inflammatory bowel disease; literate (minimum cycle) or at least the carer to be literate. Consciousness,no acceess to information other than intervention such as family members. Age between 18 to 85 years, consent to participate in the study.Exclusion criteria: Prior knowledge and informed: Patients who already have other sources of information other than the version information Such as having access to a doctor in the family, or close friends in that case, patients should be excluded;Lack of awareness;Chronic digestive diseases other than that for which the drugs.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of relapses. Timepoint: Two and four months after intervention. Method of measurement: Phone calls and questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Medical expenses. Timepoint: Two and four months after intervention. Method of measurement: Call-questionnaire.;Frequency of complications Hypochondrias. Timepoint: Two and four months after intervention. Method of measurement: Call-questionnaire.;Change in the number of drugs and dose of intake. Timepoint: Two and four months after intervention. Method of measurement: Call-questionnaire.;Quality of life. Timepoint: Two and four months after intervention. Method of measurement: Call-questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParisa Akbari Aykdh Lu
Tabriz University of Medical Sciences
Outcome results
None listed